Bezafibrate improves insulin resistance evaluated using the glucose clamp technique in patients with type 2 diabetes mellitus: a small-scale clinical study

BACKGROUND: Bezafibrate is mainly used to treat hypertriglyceridemia. Studies have reported that bezafibrate also improves type 2 diabetes mellitus, but the mechanism has not been fully elucidated. We performed euglycemic hyperinsulinemic clamps (glucose clamp) and meal tolerance tests (MTT) to exam...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Shiochi, Hideki, Ohkura, Tsuyoshi, Fujioka, Yohei, Sumi, Keisuke, Yamamoto, Naoya, Nakanishi, Risa, Matsuzawa, Kazuhiko, Izawa, Schoichiro, Ohkura, Hiroko, Inoue, Kazuoki, Ueta, Etsuko, Kato, Masahiko, Taniguchi, Shin-ichi, Yamamoto, Kazuhiro
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2014
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4213459/
https://ncbi.nlm.nih.gov/pubmed/25360162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-5996-6-113
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge